Zum Hauptinhalt springen

Hepatitiden

17. August 2018 | Hepatitiden

Kanada. How safe inhalation kits can help prevent the spread of Hepatitis C

Kanada. How safe inhalation kits can help prevent the spread of Hepatitis C Elevate NWO provides harm reduction kits as a safer alternative to bloody needles and used equipment. (CBC, Kanada, 27.07.2018) https://www.cbc.ca/news/canada/thunder-bay/…

17. August 2018 | Hepatitiden

A policy analysis exploring hepatitis C risk, prevention, testing, treatment and reinfection within Australia’s prisons

A policy analysis exploring hepatitis C risk, prevention, testing, treatment and reinfection within Australia’s prisons Lise Lafferty, T. Cameron Wild, Jake Rance and Carla Treloar Harm Reduction Journal 2018, 1…

17. August 2018 | Hepatitiden

Impact of current and scaled-up levels of hepatitis C prevention and treatment interventions for people who inject drugs in three UK settings—what is required to achieve the WHO's HCV elimination targets?.

Impact of current and scaled-up levels of hepatitis C prevention and treatment interventions for people who inject drugs in three UK settings—what is required to achieve the WHO's HCV elimination targets?. Ward, Z., Platt, L., Sweeney, S., Ho…

17. August 2018 | Hepatitiden

Hepatitis C: Gesundheitsinitiative PLUS als regionaler Ansatz

Hepatitis C: Gesundheitsinitiative PLUS als regionaler Ansatz Ein echter Meilenstein in der Medizin: Dank Therapien der neuen Generation ist Hepatitis C inzwischen bei nahezu allen Patienten heilbar. Die Weltgesundheitsorganisation (WHO) und…

17. August 2018 | Hepatitiden

High proportions of liver fibrosis and cirrhosis in an ageing population of people who use drugs in Amsterdam, The Netherlands.

High proportions of liver fibrosis and cirrhosis in an ageing population of people who use drugs in Amsterdam, The Netherlands. van Santen DK, Schim van der Loeff MF, Cartier van Dissel J, Martens JPD, van der Valk M, Prins M. Eur J Gastroenterol…

17. August 2018 | Hepatitiden

The need for a European hepatitis C programme monitoring resistance to direct-acting antiviral agents in real life to eliminate hepatitis C.

The need for a European hepatitis C programme monitoring resistance to direct-acting antiviral agents in real life to eliminate hepatitis C. Popping S, Cento V, García F, Ceccherini-Silberstein F, Seguin-Devaux C, Vijver DA, Boucher CA. J V…

17. August 2018 | Hepatitiden

Relapse or reinfection after failing hepatitis C direct acting antiviral treatment: Unravelled by phylogenetic analysis.

Relapse or reinfection after failing hepatitis C direct acting antiviral treatment: Unravelled by phylogenetic analysis. Cuypers L, Pérez AB, Chueca N, Aldamiz-Echevarría T, Alados JC, Martínez-Sapiña AM, et al. (2018)&n…

Weitere
akutelle Informationen
zu den Themengebieten